-
Pterostilbene Delays Dermal Fibroblast Senescence
2026-09-16
Zhou et al. show that pterostilbene reduces senescence phenotypes in human dermal fibroblasts by improving mitochondrial morphology, membrane potential, respiration, and mitophagy. The study connects mitochondrial quality control with preservation of collagen-related dermal function across cellular and UVB-induced mouse models.
-
FerroOrange for Live-Cell Fe²⁺ Detection
2026-09-15
FerroOrange is a live-cell Fe²⁺ fluorescent probe for connecting intracellular iron changes with ferroptosis, neuroinflammation, and metabolic stress. This workflow translates stroke-model findings into practical microscopy, flow cytometry, and plate-reader assay choices while separating validated product specifications from optimization starting points.
-
Dabigatran Etexilate: Oral Thrombin Inhibition
2026-09-15
The reference review examines dabigatran etexilate as the first oral direct thrombin inhibitor marketed in the United States, emphasizing its prodrug design, predictable anticoagulant activity, and clinical evidence across thromboembolic disorders. Its practical interpretation is balanced: reduced dependence on routine vitamin K antagonist monitoring is coupled with continued attention to bleeding risk, renal function, pharmacokinetics, and appropriate patient selection.
-
Prevotella copri, IPyA, and Breast Cancer Progression
2026-09-14
This study identifies a mechanistic gut microbiota–metabolite–host signaling axis in which Prevotella copri consumes tryptophan, lowers intrinsic indole-3-pyruvic acid, and promotes breast tumor growth through UHRF1-associated suppression of AMPK activity. Its combination of patient microbiome profiling, gnotobiotic mouse experiments, metabolite analysis, and molecular validation strengthens the case for P. copri as a progression-associated microbial risk factor while leaving important questions about human transferability.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-14
This FASEB Journal study develops a localized, nonviral strategy for restoring the tumor suppressor p21 in bladder cancer through intravesical delivery of chemically modified p21 mRNA in lipid nanoparticles. The work links bladder-restricted expression and cell-cycle disruption to tumor suppression in an orthotopic mouse model, while also identifying the delivery and translational questions that remain before clinical application.
-
Pterostilbene Preserves Mitochondrial Quality in Fibroblasts
2026-09-13
Zhou et al. show that pterostilbene mitigates human dermal fibroblast senescence in both UVB-induced stress and replicative-aging models by improving mitochondrial quality and promoting mitophagy. The study connects mitochondrial morphology, membrane potential, reactive oxygen species, respiration, and extracellular-matrix preservation, while also providing in vivo evidence from UVB-exposed mice.
-
Cell Cycle Assay Kit (Catalog No. K2263)
2026-09-12
A scenario-driven guide to DNA-content profiling, cell cycle progression analysis, and apoptosis detection by sub-G1 peak using the Cell Cycle Assay Kit (Catalog No. K2263). It connects practical flow-cytometry decisions with the reagent composition, storage requirements, and mechanistic context relevant to SKU K2263.
-
Resazurin Sodium Salt in Gut Metabolism Assays
2026-09-11
Resazurin sodium salt provides a sensitive redox readout for studying how microbial metabolites affect enteroendocrine-cell metabolism. This article explains how to use the signal intelligently without confusing metabolic suppression with cell death or proliferation.
-
Anti Reverse Cap Analog for Metabolic mRNA Assays
2026-09-11
Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, can improve synthetic mRNA translation while supporting controlled mechanistic studies. This article connects ARCA-enabled expression workflows with the TCAIM–OGDH mitochondrial proteostasis mechanism reported in Molecular Cell.
-
Hoechst 33342 in Dermal Senescence Research
2026-09-10
Hoechst 33342 is more than a blue nuclear signal in fibroblast aging studies. Used alongside mitochondrial, senescence, and extracellular-matrix readouts, it can help translational researchers connect cell-state measurements with mechanistic evidence and reproducible preclinical decisions.
-
Dihydroethidium for Applied Superoxide Assays
2026-09-10
Dihydroethidium, also called hydroethidine, turns intracellular superoxide biology into a practical live-cell red-fluorescence readout. This guide connects DHE workflow design with nanoparticle-activated cancer research, assay controls, quantitative imaging, and troubleshooting for more defensible oxidative stress measurements.
-
CCK8 Workflow for HepG2 Injury Studies
2026-09-09
Use CCK8 to convert HepG2 injury and rescue experiments into a practical, quantitative cell viability readout. Its water-soluble WST-8 chemistry supports streamlined cytotoxicity screening while careful controls distinguish genuine protection from metabolic or compound-related assay interference.
-
Annexin V: Mapping Immune Tolerance in Preeclampsia
2026-09-09
A translational perspective on how Annexin V, a calcium-dependent phosphatidylserine binding protein, can connect exosome-driven immune dysregulation with rigorous apoptosis assay design in preeclampsia research.
-
GPC3-HSP70 mRNA Nanovaccine for HCC
2026-09-08
The reference study develops an mRNA nanovaccine encoding three GPC3-derived CTL epitopes fused to HSP70 and delivered with the tumor-targeting peptide SP94. In preclinical HCC models, vaccination increased antigen-specific CD8+ T-cell activity, while combination with anti-PD-L1 therapy produced stronger antitumor effects than either strategy alone.
-
Annexin V-FITC/7-AAD Apoptosis Kit Guide
2026-09-08
Use the Annexin V-FITC/7-AAD Apoptosis Kit to distinguish viable, early apoptotic, late apoptotic, and necrotic cells in rapid cell viability and cytotoxicity workflows. The assay is especially useful for testing whether heat-treated lactoferrin retains protective bioactivity rather than merely reducing total cell loss.